The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2

The urgent response to the COVID-19 pandemic required accelerated evaluation of many approved drugs as potential antiviral agents against the causative pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Using cell-based, biochemical, and modeling approaches, we studied the appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Joy Y., Du Pont, Venice, Babusis, Darius, Gordon, Calvin J., Tchesnokov, Egor P., Perry, Jason K., Duong, Vincent, Vijjapurapu, Arya, Zhao, Xiaofeng, Chan, Julie, Cohen, Cal, Juneja, Kavita, Cihlar, Tomas, Götte, Matthias, Bilello, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267940/
https://www.ncbi.nlm.nih.gov/pubmed/35807457
http://dx.doi.org/10.3390/molecules27134212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267940/
https://www.ncbi.nlm.nih.gov/pubmed/35807457
http://dx.doi.org/10.3390/molecules27134212

Ejemplares similares